Prescription Weight Loss Medications

Weight is regulated by several overlapping systems — appetite signaling in the brain, reward and craving pathways, satiety hormones, and metabolism itself. Different medications act on different parts of that picture.

• Appetite-regulating medications (such as phentermine and phendimetrazine) quiet hunger signals so portions and snacking become easier to manage.
• Combination medications (such as Qsymia) pair two mechanisms in one capsule for a different dosing rhythm and effect profile.
• Craving-pathway medications (such as Contrave) target the reward side of eating — the pull toward food — rather than hunger alone.

Because the mechanisms differ, patient experiences differ too: tolerability, side effects, cost, dosing convenience, and results all vary from person to person. That is exactly why selection is individualized rather than one-size-fits-all.

Your provider builds the medication strategy around you — not around a default prescription. The evaluation weighs:

• Your medical history — cardiovascular health, blood pressure, other conditions, and current medications.
• Your goals and preferences — including whether you prefer an oral option over injectables.
• Prior response — what you have tried before, and how your body responded.
• Contraindications — each medication has specific screening requirements we review before anything is prescribed.
• Side-effect profile — matched against what you can comfortably tolerate.
• Cost and access — insurance coverage and affordability are legitimate clinical factors.

The outcome of that process may be one of the medications below, a GLP-1 pathway, a combination of approaches over time, or a recommendation to hold on medication while other foundations are addressed. Every pathway starts with the same thorough evaluation.

Phentermine is a well-established oral prescription medication that reduces appetite by acting on hunger signaling in the brain. It has been used for decades as a short-term aid alongside lifestyle change, and for many patients it is the most familiar entry point into prescription weight loss.

Because phentermine is mildly stimulating, its effects, screening requirements, and follow-up rhythm deserve their own full explanation — we cover mechanism, candidacy, what patients notice, and safety on the dedicated page.

Explore the full Phentermine Weight Loss page →

Phendimetrazine belongs to the same medication family as phentermine — an appetite-regulating prescription used short-term alongside nutrition and activity changes. Some patients who do not tolerate phentermine well, or who respond differently to it, may be considered for phendimetrazine instead.

Like all stimulant-class weight-loss medications, it requires cardiovascular screening, blood-pressure review, and ongoing monitoring. Whether it is appropriate for you is determined during your evaluation — it is not automatically prescribed on request.

Qsymia is a once-daily combination capsule that pairs low-dose phentermine with extended-release topiramate — bringing appetite regulation together with topiramate's complementary effects in a single medication. Its dosing follows a gradual titration schedule rather than a fixed starting dose.

Qsymia carries specific screening requirements, including strict pregnancy precautions because of its topiramate component, and it is dispensed under a structured safety program. Your provider will review whether those requirements fit your situation before considering it.

Topiramate was originally developed as a seizure medication, and its effects on appetite and satiety have led to its use — often off-label — in weight management, sometimes for patients who are not good candidates for stimulant-class options.

It requires careful dosing and monitoring, carries its own side-effect considerations and pregnancy precautions, and is not appropriate for everyone. Your provider will explain whether it belongs in your plan and what monitoring it involves.

Contrave combines two medications — naltrexone and bupropion — to work on the reward and craving side of eating rather than hunger signaling alone. For some patients, the struggle is less about portion size and more about the pull toward food, and that is the niche Contrave is designed for.

It has specific screening considerations, including blood-pressure monitoring and certain medication and condition exclusions. Whether it fits your health profile is a decision made during your evaluation.

Experiences vary by medication and by person, but patients commonly report:

• Quieter appetite or earlier satiety — with appetite-regulating medications, hunger becomes less insistent and smaller portions feel satisfying.
• Reduced food cravings — particularly with craving-pathway medications like Contrave.
• Class-specific effects — stimulant-class medications can bring a mild energy or focus lift (and possible sleep effects if taken late in the day); other classes have different effect profiles.

Weight-loss pace varies widely between individuals and depends on the medication, dose, adherence, and lifestyle changes alongside it. Your provider will set realistic expectations at your consultation rather than promising any specific result.

Every oral weight-loss medication is prescription-only because it is not appropriate for everyone — and deciding who it is right for is a medical judgment. Before anything is prescribed, your provider reviews:

• Cardiovascular history and blood pressure — especially for stimulant-class medications.
• Other medical conditions — each medication has its own exclusion list, including seizure history, eating-disorder history, and pregnancy or breastfeeding.
• Current medications — some combinations (such as MAO inhibitors) are unsafe with these medications.
• Substance-use history — relevant to several of these medication classes.

If screening shows that an oral option is not appropriate for you, we will tell you plainly and discuss alternatives — that honesty is part of the program.

Prescribing the medication is the beginning of care, not the end. Follow-up visits review your weight trend, how the medication feels, side effects, vitals, and whether the strategy should be adjusted. Some medications require specific ongoing checks, such as blood-pressure monitoring.

Monitoring is built into the program, not offered as an add-on — because a weight-loss medication should evolve with you, and problems are caught and addressed early.

Weight loss is rarely a single-medication story. Depending on your response, your provider may adjust the dose, switch to a different medication, or sequence approaches over time — moving between options as your body adapts and your goals change.

What works best at the start of your journey may not be what works best six months in. Individualized selection, sequencing, monitoring, and adjustment are the heart of the program — and we do not promise that any starting point or any specific medication produces greater cumulative weight loss.

GLP-1 medications such as semaglutide and tirzepatide work through gut-hormone signaling, affecting satiety and how the body processes food. Oral medications work through different mechanisms — appetite regulation, satiety, or craving pathways.

Neither class is universally superior. Some patients do best with a GLP-1; some prefer a daily oral option — no needles, no injection-site reactions, a familiar routine; some move between approaches over time based on response, tolerability, cost, and access. The right pathway is the one that is safe for you, sustainable for you, and matched to how your body responds.

Medication is one tool in a durable plan — not the whole plan. Lasting weight management also rests on nutrition you can sustain, activity and strength work that supports metabolic health, sleep, and periodic monitoring that catches drift early.

Many patients move through an active weight-loss phase and into maintenance with lighter support. If and when medication changes, your provider plans the transition rather than leaving it to guesswork. That long view — not the prescription itself — is what keeps results in place.